About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

G3P-01 in Volunteers With Elevated Galectin-3 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT06398821

G3P-01 in Volunteers With Elevated Galectin-3

G3P-01 is an investigational pectin extracted, enriched and purified from commercial squash puree intended for human consumption. Pectins are an important constituent of fruits and vegetables, and hea...

Lead sponsor: General Practitioners Research Institute•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

General Practitioners Research Institute

Collaborators

G3 Pharmaceuticals

Age

45 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Invited through cohort study.
•Plasma galectin-3 level of 16 ng/mL or higher
•Male and female subjects ≥45 and ≤75 years of age
•Females will be non-pregnant, non-lactating, and have no intent to become pregnant during the study period.
•Able to participate in the study in the opinion of the Investigator.
•Has the ability to understand the requirements of the study and is willing to comply with all study procedures.
•An Independent Ethics Committee or in Dutch Medisch- Ethische Toetsingscommissie (METC) -approved informed consent is signed and dated prior to any study-related activities.

Exclusion Criteria

•Existing clinically significant concurrent medical condition which in the opinion of the Investigator may interfere with the study.
•Clinically significant abnormal laboratory test values, as determined by the Investigator, at Screening.
•Participation in a clinical trial of an investigational drug within 30 days prior to Screening, or is currently participating in another trial of an investigational drug, supplement or device.

Related studies

Impact 360 for Healthy Agers

NCT06516146 · Healthy Aging

Language and Lewy Body Diseases: Sentence Comprehension Problems and Modifying Noninvasive Brain Stimulation Treatment

NCT05847985 · Lewy Body Disease, Healthy Aging

FAXAGE: Fasting And Exercise To Slow Aging In Humans

NCT07207044 · Aging, Healthy Aging, and more

The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults

NCT07231783 · Healthy Aging, Muscle Function

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

NCT07202494 · Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 9, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment48

Start dateOct 2023

Last updatedAug 9, 2024

Condition

Galectin 3 Healthy Aging

Locations shown

General Practitioners Research Institute

Groningen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions